Start your free online visit now
Read the full story here: What GLP1 users need: Food, nutrition and CPG innovation Nestl signals strategic reset in a shifting market The last month marked a critical moment for Nestl, as its CEO Phillip Navratil outlined a broader strategic overhaul aimed at sharpening focus, restoring growth and responding to changing consumer demand
One obvious possibility is that the same metabolic/hormonal abnormalities that characterize the diabetic condition in particular, elevated blood sugar, hyperinsulinemia and insulin resistance -- may also cause these complications and the associated chronic diseases
Its not yet approved, so the conversation with a doctor right now is about whats in the pipeline, whether current GLP-1 options are working, and whether to watch for survodutide trials to participate in, she said
Open, non-judgemental dialogue with healthcare professionals is essential for optimising treatment outcomes and ensuring patient safety